Yesim Dargaud/isth2023
Aug 14, 2025, 13:09
Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
“Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran – I personally think the Thrombin Generation assays could not be used for the clinical management of the patients in non replacement therapies and only show the drug concentration”
Read the full here.
Title: Utilising Thrombin Generation Assay to Guide Co-Administration of Factor Therapies With Fitusiran
Authors: Yesim Dargaud, Christophe Nougier, Stephanie Desage, Hamdi Rezigue, Amy Dericquebourg, Yohann Jourdy, Alexandre Leuci, Anne Lienhart

Discover more on Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH